OncoTherapy to apply Immunovaccine's booster technology
This article was originally published in Scrip
Executive Summary
The Japanese oncology venture OncoTherapy Science (OTS) is to investigate the application of Immunovaccine's vaccine delivery and enhancement technology to selected peptide antigens for cancer.